Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The natural history of hereditary multiple exostoses.
1994441 citationsGregory A. Schmale, E U Conrad et al.Journal of Bone and Joint Surgeryprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of E U Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E U Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E U Conrad more than expected).
This network shows the impact of papers produced by E U Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E U Conrad. The network helps show where E U Conrad may publish in the future.
Co-authorship network of co-authors of E U Conrad
This figure shows the co-authorship network connecting the top 25 collaborators of E U Conrad.
A scholar is included among the top collaborators of E U Conrad based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E U Conrad. E U Conrad is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ng, Patrick, Lanell M. Peterson, David A. Schwartz, et al.. (2003). F-18 FMISO PET tumor hypoxia imaging Investigating the tumor volume-hypoxia connection. 376.3 indexed citations
8.
Folpe, Andrew L., et al.. (2000). (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.. PubMed. 6(4). 1279–87.203 indexed citations
9.
Clayer, Mark, et al.. (1998). Tru-cut needle biopsy performed in the clinic is an accurate diagnostic tool for the management of extremity masses. Journal of Orthopaedic Science. 72(6).
10.
Eary, Janet F., E U Conrad, J D Bruckner, et al.. (1998). Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.. PubMed. 4(5). 1215–20.134 indexed citations
11.
Schreuder, H.W.B., et al.. (1998). Treatment of simple bone cysts in children with curettage and cryosurgery.. PubMed. 17(6). 814–20.48 indexed citations
Simonian, Peter T., et al.. (1995). Carcinogenicity and metallic implants.. PubMed. 24(4). 319–24.47 indexed citations
15.
Raskind, Wendy H., E U Conrad, Howard A. Chansky, & Megumi Matsushita. (1995). Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11.. PubMed. 56(5). 1132–9.125 indexed citations
16.
Schmale, Gregory A., E U Conrad, & Wendy H. Raskind. (1994). The natural history of hereditary multiple exostoses.. Journal of Bone and Joint Surgery. 76(7). 986–992.441 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.